These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14379184)

  • 21. [Development of a mouse mammary adenocarcinoma transplanted into a pneumoderma].
    ROBERT A
    Bull Assoc Fr Etud Cancer; 1954; 41(3):367-75. PubMed ID: 14363966
    [No Abstract]   [Full Text] [Related]  

  • 22. The experience of massage during chemotherapy treatment in breast cancer patients.
    Billhult A; Stener-Victorin E; Bergbom I
    Clin Nurs Res; 2007 May; 16(2):85-99; discussion 100-2. PubMed ID: 17452429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors.
    Faggioli F; Soldati S; Scanziani E; Catò EM; Adorni F; Vezzoni P; Noonan DM; Sacco MG
    Breast Cancer Res Treat; 2008 Jul; 110(2):223-6. PubMed ID: 17687642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer.
    Götte M; Kersting C; Ruggiero M; Tio J; Tulusan AH; Kiesel L; Wülfing P
    Anticancer Res; 2006; 26(1B):621-7. PubMed ID: 16739330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
    Perumal SS; Shanthi P; Sachdanandam P
    Chem Biol Interact; 2005 Feb; 152(1):49-58. PubMed ID: 15766922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
    Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
    Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
    Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
    Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies with mouse sarcoma 180.
    WEST D
    Cancer Res; 1955; Suppl. 2():363. PubMed ID: 14379193
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEG10 is a c-MYC target gene in cancer cells.
    Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
    Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy induced cytomorphologic changes in breast carcinoma: a potential diagnostic challenge for the histopathologist.
    Gupta R; Arora R; Sharma A; Dinda AK
    Indian J Pathol Microbiol; 2009; 52(4):583-5. PubMed ID: 19805986
    [No Abstract]   [Full Text] [Related]  

  • 35. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy.
    Mendes S; Graziani SR; Vitório TS; Padoveze AF; Hegg R; Bydlowski SP; Maranhão RC
    Gynecol Oncol; 2009 Feb; 112(2):400-4. PubMed ID: 19062081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies with a squamous cell stomach carcinoma of the mouse.
    ARGUS MF
    Cancer Res; 1955; Suppl. 2():1-2. PubMed ID: 14379178
    [No Abstract]   [Full Text] [Related]  

  • 38. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.
    Tsunoda-Shimizu H; Hayashi N; Hamaoka T; Kawasaki T; Tsugawa K; Yagata H; Kikuchi M; Suzuki K; Nakamura S
    Breast Cancer; 2008; 15(2):133-40. PubMed ID: 18288570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the clinical, histopathological and myoepithelial features of estrogen receptor positive and negative mammary carcinomas.
    Gucin Z; Aksoy B; Gunver F; Pasaoglu E; Bahadir F
    Saudi Med J; 2006 Apr; 27(4):470-6. PubMed ID: 16598322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive review of chemotherapy in patients with metastatic breast cancer.
    Melemed AS; Mockbee C; Orlando M
    J Clin Oncol; 2005 Nov; 23(31):8139-40. PubMed ID: 16258122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.